OncoLink en espanõl
Share
Types of Cancer > Gastrointestinal Cancers > Liver Cancer (Hepatoma) > News
November 2009
HBV reduces recurrence-free survival after surgery for hepatocellular carcinoma
October 2009
Combination therapy with sorafenib more effective in advanced liver cancer
September 2009
Universal HBV vaccination protects Asian children from liver cancer
Lapatinib shows little activity against advanced hepatocellular carcinoma
August 2009
REFILE: SAMe prevents formation of hepatocellular carcinoma in rats
SAMe prevents formation of hepatocellular carcinoma in rats
July 2009
Radiofrequency ablation decreases hepatocellular carcinoma recurrence
Hepatitis B virus mutations predict risk of hepatocellular carcinoma
June 2009
CORRECTION: Increased parity linked to reduced risk for liver cancer in women with hepatitis B
Increased parity linked to reduced risk for liver cancer in women with hepatitis B
Statin use may cut liver cancer risk in diabetics
Visceral fat tied to liver cancer recurrence
May 2009
Radiofrequency ablation more effective than ethanol injection for liver cancer
Statins may reduce hepatocellular carcinoma risk in diabetics
Bayer's Nexavar approved in Japan for liver cancer
Novel anti-HBV vaccine may prevent hepatocellular carcinoma
Hypothyroidism linked to liver cancer in women
April 2009
Radiotherapy improves outcomes of liver cancer with portal vein tumor thrombus
Laser ablation effective in early liver cancer
February 2009
Liver cancer incidence has increased since the 1970s
RF ablation linked to improved liver cancer survival
Ongoing peginterferon for HCV does not reduce liver cancer risk
Bevacizumab plus erlotinib promising in liver cancer
January 2009
Hepatitis C linked to increased risk of intrahepatic cholangiocarcinoma
December 2008
Sorafenib lengthens survival in liver cancer
November 2008
Sorafenib improves markers associated with survival in liver cancer
October 2008
Gene expression profiling predicts liver cancer survival
August 2008
High HBV viral load at surgery tied to liver cancer return
July 2008
Sorafenib slows progression of advanced liver cancer
Liver cancer surgery benefits patients with multiple tumors, portal hypertension
Bevacizumab shows significant activity in liver cancer
April 2008
Multipolar radiofrequency ablation yields high liver cancer survival rates
Adding radiofrequency ablation to chemoembolization ups liver cancer survival
RF ablation plus chemoembolization comparable to surgery for early liver cancer
February 2008
Proteomic profiling helps identify patients with liver cancer
November 2007
Bayer's Nexavar gets U.S. FDA nod for liver cancer
October 2007
Sunitinib shows promise against advanced hepatocellular carcinoma
September 2007
EU agency backs Bayer's Nexavar for liver cancer
Hypermethylated DNA in circulation of patients with HBV predicts liver cancer
August 2007
Investigational antitumor agent nolatrexed fails in phase III study of liver cancer
July 2007
Counseling tied to improved survival after gastrointestinal cancer surgery
June 2007
Coffee consumption associated with reduced liver cancer risk
October 2006
Colchicine prevents liver cancer in patients with hepatitis virus-related cirrhosis
September 2006
Colchicine may prevent hepatocellular carcinoma in patients with hepatitis
Imaging unreliable for detection of colorectal liver cancer metastases
August 2006
Neoadjuvant chemo plus resection improves survival in advanced liver cancer
EGFR mutations linked to gastrointestinal cancers
July 2006
Biomarker predicts transition of cirrhosis to hepatocellular carcinoma
DDT exposure linked to liver cancer in humans
Estrogen receptor polymorphisms tied to liver cancer
June 2006
Particle embolization aids survival in recurrent hepatocellular carcinoma
May 2006
Interferon/5-FU combination therapy may improve survival of liver cancer
April 2006
High retinol levels linked to decreased risk of liver cancer
March 2006
Percutaneous ablation offers advantages over surgery for small liver cancer
Menatetrenone improves hepatocellular carcinoma outcome
February 2006
Lamivudine curbs hepatitis B virus reactivation in liver cancer
Common type of HCV successfully cultured in hepatoma cells
November 2005
Laser ablation may be better than surgery for some liver cancers
October 2005
Iodine-131 lipiodol offers palliation in hepatocellular carcinoma
September 2005
Transplant and chemoradiation combat cholangiocarcinoma
August 2005
Radiofrequency ablation better than ethanol injection for small liver cancers
July 2005
ApoD underexpression associated with poor hepatocellular carcinoma outcome
June 2005
Tumor cell antigens serve as novel liver cancer marker
Soy intake linked with reduced hepatocellular carcinoma risk
February 2005
New scoring system points to liver cancer outcome
Hepatitis B viral load, genotype affect risk of liver cancer
January 2005
Thalidomide of little value for advanced hepatocellular carcinoma
December 2004
Radiofrequency ablation edges ethanol in liver cancer therapy
Risk factors for liver cancer identified in asymptomatic HCV
Liver cancer more aggressive in HIV-infected patients
November 2004
Liver cancer fastest growing malignancy in US: Liver Cancer Network
September 2004
Hepatitis B virus genotype C linked to increased hepatocellular carcinoma risk
Alcohol, diabetes and hepatitis boost liver cancer risk
August 2004
Prognostic factors identified for localized chemotherapy in advanced liver cancer
Porphyria cutanea tarda does not independently raise liver cancer risk
July 2004
Vitamin K2 may curb liver cancer in women with viral cirrhosis
May 2004
Hepatic resection can extend survival in hilar cholangiocarcinoma
April 2004
Radioactive microsphere therapy an option for liver cancer with poor portal flow
Renal function tied to liver cancer mortality
Hepatitis B associated with childhood hepatocellular carcinoma in Taiwan
March 2004
Preoperative needle test does not adversely affect liver cancer outcomes
February 2004
Diabetes an "important" risk factor for chronic liver disease and liver cancer
December 2003
Hereditary hemochromatosis boosts liver cancer risk
October 2003
Liver transplant extends survival in patients with liver cancer
July 2003
Steatosis identified as risk factor for liver cancer in HCV-infected patients
March 2003
Osteopontin an indicator of metastatic potential of hepatocellular carcinoma
Cisplatin gel effective against localized unresectable hepatocellular carcinoma
February 2003
Oligonucleotide IGF2 inhibitor enhances survival in hepatocellular carcinoma
January 2003
Phase III liver cancer drug trial passes safety board review
Hepatitis C-associated liver cancer risk increased in AIDS patients
December 2002
Gene amplifications tied to poor prognosis of liver cancer
IGF-1 levels predict liver cancer in patients with HCV-related cirrhosis
July 2002
Cell proliferation marker predicts liver cancer recurrence after resection
3-Bromopyruvate slays hepatoma cells in rabbits without damaging normal tissue
Presence of HBeAg associated with increased risk of liver cancer
MRI is superior to spiral CT for detection of hepatocellular carcinoma
Postprandial hyperinsulinemia accelerates growth of hepatocellular carcinoma
Youngsters with advanced liver cancer have poor prognosis
June 2002
Large hepatocellular carcinomas do not preclude resection
May 2002
Chemoembolization can prolong life in patients with unresectable liver cancer
April 2002
Green tea shows protective effect against gastrointestinal cancer
March 2002
FDA clears radiotherapy microspheres for liver cancer
February 2002
Decreased level of TIMP-2 enzyme predicts metastasis of liver cancer
Heavy drinking raises hepatocellular carcinoma risk
January 2002
Adjuvant therapy cost effective for liver cancer patients awaiting transplant
November 2001
Tamoxifen does not prolong survival in liver cancer patients
Electrolysis seen as helpful in the management of liver cancer
October 2001
Radioactive microspheres treat liver cancer
August 2001
Diabetes not a significant risk factor for primary liver cancer
Preoperative biopsy often unnecessary to diagnose hepatocellular carcinoma
July 2001
Thiazolidinediones inhibit growth of human hepatocellular carcinoma in vitro
June 2001
Tegafur/uracil prolongs survival in patients with advanced liver cancer
May 2001
Rare liver cancer on the rise in UK
Interferon-alpha reduces HCV-related hepatocellular carcinoma after resection
Megestrol improves survival for subset of patients with hepatocellular carcinoma
April 2001
Betel quid chewing increases risk of hepatocellular carcinoma
March 2001
Transarterial lipiodol benefits patients with unresectable liver cancer
February 2001
Hepatocellular carcinoma develops more rapidly in HCV-HIV coinfected patients
Age not a contraindication to hepatocellular carcinoma resection
January 2001
Interferon-alpha prevents hepatocellular carcinoma in patients with hepatitis C
Histologic grade of liver cancer affects survival after transplantation
September 2000
CT-guided techniques visualize ultrasonically invisible hepatocellular carcinoma
Chromosomal aberrations distinguish recurrent from second primary liver cancer
July 2000
Hepatitis C associated with high rate of hepatocellular carcinoma and death
May 2000
Portal vein embolization safe in injured livers before liver cancer resection
April 2000
Wide resection margin unnecessary in patients with hepatocellular carcinoma
December 1999
Hepatitis B vaccine labeling expanded to include liver cancer prevention
August 1999
High serum ALT linked to liver cancer in patients with HCV-associated cirrhosis
Interferon linked to reduced liver cancer risk in patients with chronic hepatitis C
July 1999
p73 a prognostic marker in hepatocellular carcinoma
March 1999
Chemoembolization improves survival in pediatric liver cancer patients
Heavy drinking identified as major cause of liver cancer in Japanese men
Lipiodol-iodine-131 safe, effective adjuvant in patients with resectable liver cancer
January 1999